{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:04:30Z","timestamp":1789553070569,"version":"build-2803163510"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00428-026-04565-4","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:10:40Z","timestamp":1778148640000},"page":"759-763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal cell carcinoma with a novel RAB1A::ALK fusion: expanding the molecular spectrum of ALK-rearranged RCC"],"prefix":"10.1007","volume":"489","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5516-2117","authenticated-orcid":false,"given":"Claudia Andrea","family":"G\u00f3mez Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4775-3942","authenticated-orcid":false,"given":"Banu","family":"Sarsik Kumbaraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1856-0404","authenticated-orcid":false,"given":"Fuat","family":"Kizilay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9629-5258","authenticated-orcid":false,"given":"Serdar","family":"Kalemci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1461-7485","authenticated-orcid":false,"given":"Sercan","family":"On","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-6657","authenticated-orcid":false,"given":"Sait","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"#cr-split#-4565_CR1.1","unstructured":"Argani P, Williamson SR, Inamura K (2022) Molecularly defined renal carcinomas: ALK-rearranged renal cell carcinomas. In: WHO Classification of Tumours Editorial Board. Urinary and male genital tumours [Internet]. Lyon (France):\u00a0International Agency for Research on Cancer"},{"key":"#cr-split#-4565_CR1.2","unstructured":"2022 [cited 2026 Jan 26]. (WHO classification of tumours series), 5th edn. vol 8. Available from: https:\/\/tumourclassification.iarc.who.int\/chapters\/36"},{"key":"4565_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrc3580","volume":"13","author":"B Hallberg","year":"2013","unstructured":"Hallberg B, Palmer RH (2013) Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology. Nat Rev Cancer 13:685\u2013700. https:\/\/doi.org\/10.1038\/nrc3580","journal-title":"Nat Rev Cancer"},{"key":"4565_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-025-04292-2","author":"D Arizpe","year":"2025","unstructured":"Arizpe D, Gallan AJ, Kase AM et al (2025) ALK-Rearranged renal neoplasms: update on an institutional cohort. Virchows Arch. https:\/\/doi.org\/10.1007\/s00428-025-04292-2","journal-title":"Virchows Arch"},{"key":"4565_CR4","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1038\/s41379-020-0578-0","volume":"33","author":"N Kuroda","year":"2020","unstructured":"Kuroda N, Trpkov K, Gao Y et al (2020) ) ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217. Mod Pathol 33:2564\u20132579. https:\/\/doi.org\/10.1038\/s41379-020-0578-0","journal-title":"Mod Pathol"},{"key":"4565_CR5","doi-asserted-by":"publisher","first-page":"100536","DOI":"10.1016\/j.modpat.2024.100536","volume":"37","author":"M Zhao","year":"2024","unstructured":"Zhao M, Yin X, Yang X et al (2024) ALK-Rearranged Renal Cell Carcinoma: A Multi-Institutional Study of 9 Cases With Expanding the Morphologic and Molecular Genetic Spectrum. Mod Pathol 37:100536. https:\/\/doi.org\/10.1016\/j.modpat.2024.100536","journal-title":"Mod Pathol"},{"key":"4565_CR6","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1002\/cncr.31578","volume":"124","author":"MM Cajaiba","year":"2018","unstructured":"Cajaiba MM, Dyer LM, Geller JI et al (2018) The classification of pediatric and young adult renal cell carcinomas registered on the children\u2019s oncology group (COG) protocol AREN03B2 after focused genetic testing. Cancer 124:3381\u20133389. https:\/\/doi.org\/10.1002\/cncr.31578","journal-title":"Cancer"},{"key":"4565_CR7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/modpathol.2010.213","volume":"24","author":"LV Debelenko","year":"2011","unstructured":"Debelenko LV, Raimondi SC, Daw N et al (2011) Renal cell carcinoma with novel VCL\u2013ALK fusion: new representative of ALK-associated tumor spectrum. Mod Pathol 24:430\u2013442. https:\/\/doi.org\/10.1038\/modpathol.2010.213","journal-title":"Mod Pathol"},{"key":"4565_CR8","doi-asserted-by":"publisher","first-page":"200528","DOI":"10.1016\/j.ehpc.2021.200528","volume":"25","author":"AR Sangoi","year":"2021","unstructured":"Sangoi AR, Kimm SY, Chan E (2021) VCL-ALK renal cell carcinoma in adult patient without sickle cell trait. Hum Pathology: Case Rep 25:200528. https:\/\/doi.org\/10.1016\/j.ehpc.2021.200528","journal-title":"Hum Pathology: Case Rep"},{"key":"4565_CR9","doi-asserted-by":"publisher","first-page":"102266","DOI":"10.1016\/j.clgc.2024.102266","volume":"23","author":"X Zhang","year":"2025","unstructured":"Zhang X, Ban C, Chen Y et al (2025) ALK-Rearranged Renal Cell Carcinoma: A Study of Three Cases With Clinicopathologic Features and Effect of Postoperative Adjuvant Immunotherapy. Clin Genitourin Cancer 23:102266. https:\/\/doi.org\/10.1016\/j.clgc.2024.102266","journal-title":"Clin Genitourin Cancer"},{"key":"4565_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cancergen.2017.11.010","volume":"221","author":"Y Bodokh","year":"2018","unstructured":"Bodokh Y, Ambrosetti D, Kubiniek V et al (2018) ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review. Cancer Genet 221:31\u201337. https:\/\/doi.org\/10.1016\/j.cancergen.2017.11.010","journal-title":"Cancer Genet"},{"key":"4565_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/PAP.0000000000000426","volume":"31","author":"Y-B Chen","year":"2024","unstructured":"Chen Y-B (2024) Update on Selected High-grade Renal Cell Carcinomas of the Kidney: FH-deficient, ALK-rearranged, and Medullary Carcinomas. Adv Anat Pathol 31:118\u2013125. https:\/\/doi.org\/10.1097\/PAP.0000000000000426","journal-title":"Adv Anat Pathol"},{"key":"4565_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1152\/physrev.00059.2009","volume":"91","author":"AH Hutagalung","year":"2011","unstructured":"Hutagalung AH, Novick PJ (2011) Role of Rab GTPases in Membrane Traffic and Cell Physiology. Physiol Rev 91:119\u2013149. https:\/\/doi.org\/10.1152\/physrev.00059.2009","journal-title":"Physiol Rev"},{"key":"4565_CR13","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1038\/s41598-023-33955-w","volume":"13","author":"H Li","year":"2023","unstructured":"Li H, Cheng Z, Jiang B et al (2023) Prognosis value and positive association of Rab1A\/IL4R\u03b1 aberrant expression in gastric cancer. Sci Rep 13:6964. https:\/\/doi.org\/10.1038\/s41598-023-33955-w","journal-title":"Sci Rep"},{"key":"4565_CR14","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.3390\/ijms23073995","volume":"23","author":"GM Iannantuono","year":"2022","unstructured":"Iannantuono GM, Riondino S, Sganga S et al (2022) Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review. Int J Mol Sci 23:3995. https:\/\/doi.org\/10.3390\/ijms23073995","journal-title":"Int J Mol Sci"},{"key":"4565_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.eururo.2018.03.032","volume":"74","author":"SK Pal","year":"2018","unstructured":"Pal SK, Bergerot P, Dizman N et al (2018) Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma. Eur Urol 74:124\u2013128. https:\/\/doi.org\/10.1016\/j.eururo.2018.03.032","journal-title":"Eur Urol"}],"updated-by":[{"DOI":"10.1007\/s00428-026-04602-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000}}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04565-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04565-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04565-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:23:24Z","timestamp":1789550604000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04565-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4565"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04565-4","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00428-026-04602-2","URL":"https:\/\/doi.org\/10.1007\/s00428-026-04602-2","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This case report was approved by the Clinical Ethics Committee of Ege University Hospital (Approval No: 2025-6733-26-1T\/13)","order":1,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report there are no competing interests to declare.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}